Recherche
-
Depressive symptoms in obesity: Relative contribution of low-grade inflammation and metabolic health
(Psychoneuroendocrinology. vol. 91, pp. 55-61, 2018-05)Article de revue -
Reward-related brain activity and behavior are associated with peripheral ghrelin levels in obesity
(Psychoneuroendocrinology. vol. 112, pp. 104520, 2020)Article de revue -
Tryptophan metabolic pathways are altered in obesity and are associated with systemic inflammation
(Frontiers in Immunology. vol. 11, pp. 1-7, 2020-04)Article de revueLibre accès -
Low-grade inflammation is a major contributor of impaired attentional set shifting in obese subjects
(Brain, Behavior, and Immunity. vol. 58, pp. 63-68, 2016-11)Article de revue -
History of major depression is associated with neuropsychiatric symptoms but not systemic inflammation in a cross-sectional study in obese patients
(Brain, Behavior, and Immunity. vol. 76, pp. 215-222, 2019)Article de revue -
Fatigue symptoms relate to systemic inflammation in patients with type 2 diabetes.
(Brain, Behavior, and Immunity. vol. 26, n° 8, pp. 1211-9, 2012-11-01)Article de revue -
History of depression is associated with neuropsychiatric symptoms and augmented inflammatory markers in a cross sectional study on obese patients
(European Neuropsychopharmacology. vol. 27, pp. S627-S628, 2017)Article de revue -
Association between the indole pathway of tryptophan metabolism and subclinical depressive symptoms in obesity: a preliminary study
(International Journal of Obesity. vol. 46, n° 4, pp. 885-888, 2022-01-10)Article de revue -
Adipose inflammation in obesity: relationship with circulating levels of inflammatory markers and association with surgery-induced weight loss.
(Journal of Clinical Endocrinology and Metabolism. vol. 99, n° 1, pp. E53-61, 2014-01-01)Article de revue -
Depressive symptoms in obese subjects are related to systemic inflammation but not metabolic health
(Journée NeuroCampus, Journée NeuroCampus, fr, Bordeaux, 2017-04)Communication dans un congrès avec actes